The Cooper Companies, Inc. (NASDAQ:COO) Receives $109.48 Consensus Price Target from Analysts

Shares of The Cooper Companies, Inc. (NASDAQ:COO) have been given a consensus rating of “Moderate Buy” by the ten analysts that are presently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $109.48.

COO has been the topic of several recent research reports. Stifel Nicolaus reiterated a “buy” rating and issued a $110.00 price objective (up previously from $105.00) on shares of Cooper Companies in a research note on Friday, March 1st. Mizuho increased their price objective on shares of Cooper Companies from $102.50 to $115.00 and gave the stock a “buy” rating in a research note on Friday, March 1st. JPMorgan Chase & Co. upgraded shares of Cooper Companies from a “neutral” rating to an “overweight” rating and increased their price objective for the stock from $100.00 to $120.00 in a research note on Wednesday, March 13th. TheStreet cut shares of Cooper Companies from a “b-” rating to a “c” rating in a research note on Thursday, February 29th. Finally, Citigroup increased their price objective on shares of Cooper Companies from $108.00 to $116.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd.

Cooper Companies Stock Performance

Shares of COO stock opened at $92.04 on Tuesday. Cooper Companies has a one year low of $75.93 and a one year high of $104.07. The company’s 50-day moving average is $98.02 and its 200 day moving average is $90.84. The company has a market capitalization of $18.29 billion, a price-to-earnings ratio of 62.93, a price-to-earnings-growth ratio of 2.37 and a beta of 0.94. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.08 and a current ratio of 1.86.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, February 29th. The medical device company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.78 by $0.07. The company had revenue of $931.60 million for the quarter, compared to the consensus estimate of $915.93 million. Cooper Companies had a net margin of 7.93% and a return on equity of 8.79%. Cooper Companies’s revenue for the quarter was up 8.5% on a year-over-year basis. During the same period in the prior year, the firm posted $2.90 EPS. Sell-side analysts expect that Cooper Companies will post 3.5 EPS for the current fiscal year.

Insider Activity at Cooper Companies

In related news, Director Gary S. Petersmeyer sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $103.51, for a total value of $103,510.00. Following the sale, the director now owns 5,668 shares in the company, valued at $586,694.68. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Cooper Companies news, Director Gary S. Petersmeyer sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $103.51, for a total value of $103,510.00. Following the completion of the transaction, the director now directly owns 5,668 shares of the company’s stock, valued at $586,694.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Agostino Ricupati sold 54,724 shares of the company’s stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $100.89, for a total value of $5,521,104.36. Following the transaction, the chief accounting officer now directly owns 5,081 shares of the company’s stock, valued at $512,622.09. The disclosure for this sale can be found here. 2.00% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in COO. Lipe & Dalton grew its holdings in Cooper Companies by 0.9% in the 4th quarter. Lipe & Dalton now owns 3,360 shares of the medical device company’s stock valued at $1,272,000 after buying an additional 30 shares in the last quarter. WD Rutherford LLC grew its holdings in shares of Cooper Companies by 0.4% during the 4th quarter. WD Rutherford LLC now owns 9,126 shares of the medical device company’s stock worth $3,541,000 after purchasing an additional 33 shares during the period. Blue Trust Inc. grew its holdings in shares of Cooper Companies by 54.8% during the 4th quarter. Blue Trust Inc. now owns 96 shares of the medical device company’s stock worth $36,000 after purchasing an additional 34 shares during the period. Loomis Sayles & Co. L P grew its holdings in shares of Cooper Companies by 26.5% during the 3rd quarter. Loomis Sayles & Co. L P now owns 167 shares of the medical device company’s stock worth $53,000 after purchasing an additional 35 shares during the period. Finally, Moneta Group Investment Advisors LLC grew its holdings in shares of Cooper Companies by 2.7% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 1,386 shares of the medical device company’s stock worth $458,000 after purchasing an additional 37 shares during the period. 24.39% of the stock is owned by institutional investors and hedge funds.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.